KEQU Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
66.3M
-7.1%
71.4M
+2.9%
69.4M
-1.0%
70.1M
-1.4%
71.1M
Cost of Revenue
46.7M
-6.9%
50.2M
-1.4%
50.9M
+0.9%
50.4M
+0.4%
50.2M
Gross Profit
19.6M
-7.6%
21.2M
+14.6%
18.5M
-6.0%
19.7M
-5.8%
20.9M
Operating Expenses
16.5M
+2.8%
16.0M
+0.4%
16.0M
+2.2%
15.6M
-3.1%
16.1M
R&D
0
0
0
0
0
SG&A
0
0
0
0
0
Operating Income
3.2M
-39.5%
5.2M
+102.0%
2.6M
-37.1%
4.1M
-14.6%
4.8M
EBITDA
4.7M
-35.3%
7.3M
+75.6%
4.2M
-26.5%
5.7M
-10.6%
6.4M
Net Income
1.8M
-50.1%
3.7M
+243.1%
1.1M
-57.6%
2.5M
-19.7%
3.2M
EPS (Basic)
$0.59
-50.0%
$1.18
+391.7%
$0.24
-71.8%
$0.85
-21.3%
$1.08
EPS (Diluted)
$0.58
-48.7%
$1.13
+391.3%
$0.23
-72.0%
$0.82
-21.2%
$1.04
Shares (Diluted)
2.9M
-2.5%
3.0M
+0.4%
3.0M
-0.2%
3.0M
+0.9%
3.0M
Kewaunee Scientific (KEQU) โ€” Financials